Abstract

Genome editing describes a variety of molecular biology applications enabling targeted and precise alterations of the genomes of plants, animals and microorganisms. These rapidly developing techniques are likely to revolutionize the breeding of new crop varieties. Since genome editing can lead to the development of plants that could also have come into existence naturally or by conventional breeding techniques, there are strong arguments that these cases should not be classified as genetically modified organisms (GMOs) and be regulated no differently from conventionally bred crops. If a specific regulation would be regarded necessary, the application of genome editing for crop development may challenge risk assessment and post-market monitoring. In the session “Plant genome editing—any novel features to consider for ERA and regulation?” held at the 14th ISBGMO, scientists from various disciplines as well as regulators, risk assessors and potential users of the new technologies were brought together for a knowledge-based discussion to identify knowledge gaps and analyze scenarios for the introduction of genome-edited crops into the environment. It was aimed to enable an open exchange forum on the regulatory approaches, ethical aspects and decision-making considerations.

Highlights

  • New plant breeding techniques, such as genome editing, enable a previously unachievable targeted and precise modification of the genome

  • Shall the types of genome edited crops that could have been created by conventional breeding techniques be regulated no differently from conventionally bred crops? Does the current scientific development represent the ultimate trigger to design a novel framework for risk assessment which focusses on the product and its potential effects on health and environment irrespective of the technique used to develop it, as suggested by Conko et al (2016)?. To help answer these questions, the session “Plant genome editing—any novel features to consider for ecological risk assessment (ERA) and regulation?” held at the 14th ISBGMO4, used both, expert presentations and an interactive “World Café” discussion to bring together scientists from various disciplines as well as regulators, risk assessors and potential users of the new technologies

  • Regulatory systems may face additional challenges posed by genome-edited products, which were discussed by Martin Lema. These include for instance the debate between technology-based and product-based regulations and the potential impact on product monitoring: The Core Issue of Regulatory Touchstones Debates regarding the regulatory status of genome-edited organisms generally follow a comparative approach with genetically modified organisms (GMOs) and with conventional organisms obtained by mutation and breeding

Read more

Summary

Frontiers in Bioengineering and Biotechnology

Genome editing describes a variety of molecular biology applications enabling targeted and precise alterations of the genomes of plants, animals and microorganisms. These rapidly developing techniques are likely to revolutionize the breeding of new crop varieties. Since genome editing can lead to the development of plants that could have come into existence naturally or by conventional breeding techniques, there are strong arguments that these cases should not be classified as genetically modified organisms (GMOs) and be regulated no differently from conventionally bred crops. If a specific regulation would be regarded necessary, the application of genome editing for crop development may challenge risk assessment and post-market monitoring.

INTRODUCTION
Harmonization of Regulation
CONCLUSION
AUTHOR CONTRIBUTIONS
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.